Tiny radioactive beads for glioma that has come back
Official title: Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study is testing whether tiny radioactive beads, placed in the blood vessels that feed a brain tumor, can treat it safely.
Read our full plain-language summary
What the trial team says
This study is testing a new way of treating brain tumours using tiny radioactive beads called SIR-Spheres® (90Y-labelled Resin Microspheres). These microspheres are placed into the blood vessels that feed the tumour. The treatment gives off radiation inside the tumour to try to stop it from growing. This type of treatment is called Selective Internal Radiation Therapy (SIRT), Transarterial Radioembolisation (TARE), or radioembolisation. It is already an accepted treatment for patients with liver cancer. In this study, we are testing if this treatment can be done safely in the brain and how well it works.
Key facts
- Registry number
- NCT07712770
- Stage of testing
- Early phase 1
- Conditions studied
- Recurrent Glioblastoma IDH Wildtype, Recurrent Glioblastoma
Where it is running
This trial lists 1 site.
-
Victoria
- Austin Hospital (Melbourne)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.